全文获取类型
收费全文 | 4124篇 |
免费 | 389篇 |
国内免费 | 141篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 55篇 |
妇产科学 | 1篇 |
基础医学 | 364篇 |
口腔科学 | 34篇 |
临床医学 | 301篇 |
内科学 | 1730篇 |
皮肤病学 | 69篇 |
神经病学 | 34篇 |
特种医学 | 44篇 |
外科学 | 216篇 |
综合类 | 607篇 |
现状与发展 | 3篇 |
预防医学 | 108篇 |
眼科学 | 27篇 |
药学 | 375篇 |
中国医学 | 638篇 |
肿瘤学 | 47篇 |
出版年
2024年 | 25篇 |
2023年 | 119篇 |
2022年 | 148篇 |
2021年 | 270篇 |
2020年 | 244篇 |
2019年 | 225篇 |
2018年 | 155篇 |
2017年 | 184篇 |
2016年 | 181篇 |
2015年 | 156篇 |
2014年 | 253篇 |
2013年 | 445篇 |
2012年 | 203篇 |
2011年 | 215篇 |
2010年 | 183篇 |
2009年 | 149篇 |
2008年 | 143篇 |
2007年 | 154篇 |
2006年 | 130篇 |
2005年 | 119篇 |
2004年 | 101篇 |
2003年 | 98篇 |
2002年 | 89篇 |
2001年 | 88篇 |
2000年 | 90篇 |
1999年 | 57篇 |
1998年 | 59篇 |
1997年 | 46篇 |
1996年 | 41篇 |
1995年 | 44篇 |
1994年 | 29篇 |
1993年 | 31篇 |
1992年 | 20篇 |
1991年 | 20篇 |
1990年 | 20篇 |
1989年 | 22篇 |
1988年 | 22篇 |
1987年 | 14篇 |
1986年 | 16篇 |
1985年 | 8篇 |
1984年 | 8篇 |
1983年 | 5篇 |
1982年 | 6篇 |
1981年 | 6篇 |
1980年 | 7篇 |
1978年 | 4篇 |
1977年 | 1篇 |
1974年 | 1篇 |
排序方式: 共有4654条查询结果,搜索用时 31 毫秒
1.
《Journal of pediatric surgery》2023,58(5):856-861
Background/PurposeA small number of Hirschsprung disease (HD) patients develop inflammatory bowel disease (IBD)-like symptoms after pullthrough surgery. The etiology and pathophysiology of Hirschsprung-associated IBD (HD-IBD) remains unknown. This study aims to further characterize HD-IBD, to identify potential risk factors and to evaluate response to treatment in a large group of patients.MethodsRetrospective study of patients diagnosed with IBD after pullthrough surgery between 2000 and 2021 at 17 institutions. Data regarding clinical presentation and course of HD and IBD were reviewed. Effectiveness of medical therapy for IBD was recorded using a Likert scale.ResultsThere were 55 patients (78% male). 50% (n = 28) had long segment disease. Hirschsprung-associated enterocolitis (HAEC) was reported in 68% (n = 36). Ten patients (18%) had Trisomy 21. IBD was diagnosed after age 5 in 63% (n = 34). IBD presentation consisted of colonic or small bowel inflammation resembling IBD in 69% (n = 38), unexplained or persistent fistula in 18% (n = 10) and unexplained HAEC >5 years old or unresponsive to standard treatment in 13% (n = 7). Biological agents were the most effective (80%) medications. A third of patients required a surgical procedure for IBD.ConclusionMore than half of the patients were diagnosed with HD-IBD after 5 years old. Long segment disease, HAEC after pull through operation and trisomy 21 may represent risk factors for this condition. Investigation for possible IBD should be considered in children with unexplained fistulae, HAEC beyond the age of 5 or unresponsive to standard therapy, and symptoms suggestive of IBD. Biological agents were the most effective medical treatment.Level of EvidenceLevel 4 相似文献
2.
3.
目的探讨化浊解毒方治疗溃疡性结肠炎(UC)的治疗作用及机制。方法120例UC患者按照随机数字表法分为观察组、对照组各60例。观察组予中药化浊解毒方口服,每日1剂,早晚2次温服;对照组予美沙拉嗪肠溶片口服,1.0 g/次,3次/d。2组疗程均4周。对比2组治疗前后Geboes指数、结肠镜下黏膜表现、生活质量评分、疾病活动指数及血清炎性因子IL-8、IL-35水平,凝血指标血清FIB水平,统计治疗后1年内复发情况。结果治疗后,观察组Geboes指数、疾病活动指数及血清炎性因子IL-8水平、凝血指标血清FIB水平均较本组治疗前降低,生活质量评分、血清炎性因子IL-35水平升高(P<0.05);且观察组治疗后疾病活动指数及血清炎性因子IL-8水平、凝血指标血清FIB水平均低于对照组,生活质量评分、血清炎性因子IL-35水平均高于对照组(P<0.05)。与对照组相比,治疗组糜烂、溃疡改善不明显(P>0.05),充血水肿、颗粒样变等肠镜表现改善情况均优于对照组(P<0.05)。治疗结束1年观察组复发率为10.64%,对照组为23.53%,2组差异有统计学意义(P<0.05)。结论化浊解毒方能改善UC患者临床症状,修复肠黏膜病理损伤,降低复发率;其机制可能与调节血清炎性因子IL-8、IL-35和凝血因子FIB水平有关。 相似文献
4.
溃疡性结肠炎内镜、病理特点及其临床意义 总被引:3,自引:0,他引:3
目的探讨溃疡性结肠炎内镜及病理组织学检查的临床特点及其意义。方法采用分级的方法描述219例活动期溃疡性结肠炎以及53例治疗后临床症状完全缓解者的内镜、病理组织学特点。运用Spearman等级相关系数进行相关分析。结果本组219例活动期溃疡性结肠炎内镜分级主要分布在Ⅱ~Ⅲ级,占59.8%。病理组织学分级主要分布在Ⅲ~Ⅳ级,占79.9%(r=0.1692,P=0.0122)。经治疗后4周~8个月间,53例临床症状完全消失。内镜分级由治疗前的Ⅲ~Ⅳ级向Ⅰ~Ⅱ级转归,而病理组织学分级Ⅳ级为22.7%(r=0.3007,P=0.0287)。内镜分级与病理组织学分级两者间均无相关性。结论本组内镜及病理组织学分级描述溃疡性结肠炎病情以及疗效有不一致性。早期诊断以及近期疗效的判断不仅应依靠临床症状及内镜检查所见,更应结合病理组织学检查。 相似文献
5.
目的探讨全结肠切除后三环形回肠贮袋-肛管吻合加选择性截流术的价值。方法1994年9月至2004年9月对18例全结肠切除患者应用三环形回肠贮袋加选择性截流术,其中家族性大肠腺瘤性息肉病14例,溃疡性结肠炎4例。结果18例获12月~5年随访,无手术死亡。术后发生并发症3例(16.7%),贮袋阴道瘘、早期炎性肠梗阻、切口感染各1例,均治愈。术后平均排便频率:术后2周内4.9次/d,1个月3.8次/d,6个月3.1次/d,1年1.8次/d。至6个月时都能控制干便,其中控制正常者15例(83.3%),控制欠佳者3例(16.7%),无大便失禁。但稀便控制能力较差,至1年时仍有1例(5.6%)患者稀便失禁。无一例须插管排空。结论全结肠切除后三环形回肠贮袋肛管吻合加选择性截流术操作简单,手术并发症少,术后排便功能好,是家族性大肠腺瘤性息肉病和严重溃疡性结肠炎全结肠切除后较为合适的消化道重建方式。 相似文献
6.
目的 建立小鼠溃疡性结肠炎模型。方法 给小鼠自由饮用5%葡聚糖硫酸钠(DSS)溶液7d后,改为蒸馏水自由饮用10d,如此进行4个循环,每天观察症状。在第1个循环和第4个循环后剖杀小鼠,取出整段结肠行实体显微镜观察及切片组织学研究。结果 所观察的症状、实体显微镜像、组织学病理改变均与人类溃疡性结肠炎类似。结论 此模型制作方法简便,重复性良好,可应用于多种实验研究。 相似文献
7.
ABSTRACT. Serum concentrations of sulphasalazine and sulphapyridine were measured during the first week of life in 15 children whose mothers had been on sulphasalazine during pregnancy. The serum concentrations of sulphapyridine and sulphasalazine were similar in the children and their mothers at delivery. The elimination rate of the drugs in the newborn children was slow but the concentrations were not so high that a bilirubin displacing effect could be expected. In eight mothers who were breast-feeding and taking sulphasalazine, analyses were done of mothers'serum, breast-milk and serum from their children. The results showed that the amount of sulphasalazine and sulphapyridine transferred to the child via the breast-milk is negligible with regard to the risk of kernicterus. It is concluded that a woman in need of sulphasalazine treatment can continue the medication throughout pregnancy and lactation without risk of development of kernicterus in her child. Only term infants without haemolytic disease were included in the study. Thus our conclusion is not necessarily valid for the prematurely born child or the child with haemolytic disease. 相似文献
8.
9.
目的探讨全结直肠切除回肠贮袋肛管吻合术(ileal pouch-anal anastomosis,IPAA)后患者控便能力与肛管压力的关系。方法对16例患者行IPAA术,术后1个月、6个月、1年时随访控便能力,并检测肛管压力。结果12例获得随访,平均2.3(1.0~4.5)年,患者排便次数在术后1年时明显少于术前和术后1个月(P<0.05);肛管静息压和最大缩柞压在术后1个月、6个月时明显低于术前(P<0.05),但在术后1年时已有明显改善,与术前相似(P>0.05)。结论IPAA术后肛管压力的改变可能与患者的控便能力有关。 相似文献
10.
M Daperno R Sostegni N Scaglione E Ercole C Rigazio R Rocca A Pera 《Digestive and liver disease》2004,36(1):21-28
BACKGROUND: Severe ulcerative colitis is potentially life threatening even though a policy of intensive medical management and early colectomy in recent years reduced mortality to almost zero. However, colectomy, with or without ileal-anal anastomosis, has its own problems (morbidity, pouchitis, cuffitis) and no reliable prognostic index of surgical outcome has been developed. Intravenous steroids are still the mainstay of medical therapy but their maximal duration before stating a 'treatment failure' has not been defined. AIM OF THE STUDY: To evaluate the effectiveness, safety and outcome of an intensive medical approach in a series of patients with severe ulcerative colitis. PATIENTS AND METHODS: One hundred and forty-nine episodes of severe ulcerative colitis in 115 patients admitted to a Gastroenterology Unit in a 7-year period were retrospectively evaluated. Intravenous glucocorticosteroids--methylprednisolone 1 mg/kg/day--and topical steroids were administered, and supportive treatments with intensive monitoring were extended to all the patients. Second-line strategies for steroid-refractoriness were prolonged glucocorticosteroids treatment, oral ciclosporin, infliximab or surgery. RESULTS: The median number of Truelove criteria at admission was 3 (range 2-5), median CRP 34 mg/l (range 10-196). Median follow-up after discharge was 49 months. In 84 (57%) episodes an early response was noted, while 65 (43%) did not respond within 10 days to the standard steroid treatment. In the non-responders group, 28 patients went into remission with a prolonged steroid treatment (slow responders); 15 patients were treated with ciclosporin (eight responders) and 6 with infliximab (four responders). A total of 24 colectomies was performed in this group of patients (in 21 cases within 30 days from admission). Slow responders showed lower albumin levels (P = 0.02), higher cumulative dose of glucocorticosteroids in the year prior to admission (P = 0.02) and higher age (P = 0.03), in comparison with early responders. Major complications were noted in four episodes which responded to medical treatment. Disease-related mortality was zero. CONCLUSIONS: Medical treatment and use of second-line therapies were effective in the present series of patients. A group of slow responders has been identified and, if an intensive medical monitoring is guaranteed, steroids can be safely prolonged after the first 10 days of treatment. Cumulatively, about 80% of the patients responded to short-term medical treatment, only 5% of the patients underwent colectomy in the follow-up period. Major adverse events were recorded in four patients, who had recovered completely after adequate medical treatment. 相似文献